Poly [ADP-ribose] polymerase 1 (PARP-1) is the founding member of the PARP family of enzymes which promotes the formation of ADP-ribose polymers (PARs) and their addition to PARP-1 itself and other acceptor proteins in a process referred to as PARylation. 1 PARP-1 is an abundant nuclear chromatin-associated protein involved in a plethora of functions such as DNA repair, recombination, cell proliferation and death, inflammation and gene transcription.
| INTRODUC TI ON
Poly [ADP-ribose] polymerase 1 (PARP-1) is the founding member of the PARP family of enzymes which promotes the formation of ADP-ribose polymers (PARs) and their addition to PARP-1 itself and other acceptor proteins in a process referred to as PARylation. 1 PARP-1 is an abundant nuclear chromatin-associated protein involved in a plethora of functions such as DNA repair, recombination, cell proliferation and death, inflammation and gene transcription.
The regulatory functions of PARP-1 were established after its discovery four decades ago, and the initially described role in DNA repair was followed by confirmation of its involvement in transcriptional regulation. The link between PARP-1 and epigenetic events was hypothesised in light of its role related to genome stability and histone PARylation that leads to chromatin opening resembling the outcome of histone acetylation. The regulation of DNA demethylation is a newly discovered housekeeping role of PARP-1, which is realized through interaction with ten-eleven translocation enzymes 1 (TET1) and the ability of PARP-1 to PARylate TET1 both covalently and noncovalently. 2 converts 5mC to 5-hydroxymethylcyosine (5hmC) and then to 5-formylcytosine (5fc) and 5-carboxylcytosine (5caC) by the action of the TET family of dioxygenases (TET1, TET2 and TET3). The DNA repair pathways remove 5fc and 5caC, rendering the cytosine unmethylated, with these sequential modifications of 5mC comprising the active DNA demethylation processes. 3, 4 5hmC is mainly associated with promoter proximal regions or distal regulatory elements within CpG islands, which indicates its involvement in transcriptional regulation of gene expression. 2 We previously reported that PARP-1 has a pivotal role in suppressing the Cxcl12 gene promoter 5 as a transcriptional regulator with a strong binding affinity for the Cxcl12 promoter. CXCL12 is a chemokine produced in stromal tissues in multiple organs. CXCL12
is a potent chemoattractant involved in angiogenesis, leucocyte trafficking, stem cell homing and in processes including development, cell survival, tissue repair and regeneration. 6 CXCL12 plays an important role in β-cell differentiation, pancreatic islet genesis and in anti-apoptotic/anti-necrotic protection of β-cells from diabetogenic agents. 7, 8 Moreover, CXCL12 is as an important player in various diseases (including cancer, inflammatory disorders, atherosclerosis, HIV pathology and diabetes), 9, 10 hence the biological significance of methylation-dependent regulation of the Cxcl12 gene.
Our previous results regarding PARP-1-related suppression of
Cxcl12 raised the question whether this regulatory role of PARP-1 controls Cxcl12 expression via an epigenetic mechanism. To address this possibility, we examined whether epigenetic events such as primary DNA de/methylation drive PARP-1-mediated suppression of Cxcl12 gene expression. These concentrations correspond to the EC 50 for the two cell lines.
| MATERIAL S AND ME THODS

| Cell culture and treatments
| Immunoblot analysis
Secreted proteins were precipitated with 13% trichloroacetic acid from the serum-free culture media in which NIH3T3 and PARP1−/− cells were cultivated for 24 hours. These samples were separated by 15% tricine-sodium dodecyl sulphate-polyacrylamide gel electrophoresis (tricine-SDS-PAGE) and electrotransferred onto a polyvinylidene difluoride membrane. Immunoblotting was performed using the anti-CXCL12 primary antibody (FL-93, Santa Cruz Biotechnology, Santa Cruz, CA, USA) incubated overnight at 4°C, followed by incubation with horseradish peroxidase-conjugated anti-rabbit secondary antibody at room temperature for 1 hour. 
| P CR-BA S ED ME THYL ATION ANALYS IS
For DNA methylation analysis, four sets of primers were designed in MethPrimer (http://www.urogene.org/methprimer2/) which encompass four regions of the Cxcl12 gene: part of the promoter (1MU), the TSS, the exon-intron boundary (2MU) and part of the intron (3MU).
Each set of primers consists of two primer pairs, one specific for methylated (M) and the other for unmethylated (U) bisulphite-converted sequence. The same primers were used for both methylationspecific PCR (MSP) and high resolution melting analysis (HRM) ( Table   S2 ). In MSP, each primer pair was used in separate reactions while for HRM, both M and U primers from the same set were combined in a Statistical tests were performed using log2 transformed data; the mean values and error bars were back transformed to linear scale for graphs. Statistical significance was estimated using paired t test by pairing NIH3T3 and PARP1−/− samples that were isolated
simultaneously. In HRM analysis, the melting temperatures were determined from derivative melting curves and these temperatures were used for assessing and comparing overall methylation levels of the target regions.
| In situ nuclear HALO preparation and immunostaining
Nuclear HALOs were prepared as previously described. 13 In brief, 
| Assessment of global levels of DNA methylation
Global methylation levels were measured by the 5-mC DNA ELISA kit (Zymo Research, California, USA) according to the manufacturer's protocol and guidelines. Statistical significance was estimated using one-way ANOVA with blocking, treating each ELISA plate as a block.
| RE SULTS
| The level of Cxcl12 expression in PARP1−/− cells compared to NIH3T3
Cxcl12 expression in NIH3T3 and PARP1−/− cells is presented in Figure 1A . Real-time PCR showed that in the absence of PARP-1, the expression of Cxcl12 in the PARP1−/− was much higher (1.3 × 10 We also analysed the same target regions with HRM, which provided information about the methylation of the whole amplicon ( Figure 3) . Unsurprisingly, the results of HRM analysis were in line with MSP findings, as the measured melting temperatures were consistently higher for NIH3T3 than for PARP1−/− samples for all four amplicons, indicating that there was an overall higher level of methylation in NIH3T3 cells over the entire length of the analysed target sequences. Namely, the largest difference in melting temperatures was observed for the exon-intron boundary region (5.2°C), followed by the promoter and intron regions (respectively 2.2°C and 2°C), with the smallest difference observed for the TSS region (1.7°C).
| Examining the global level of DNA methylation in NIH3T3 and PARP1−/− cells
To better understand the local differential methylation patterns be- F I G U R E 3 Methylation levels of different parts of Cxcl12 gene in PARP−/− compared to NIH3T3 cell lines measured by methylationspecific PCR (MSP) or high-resolution melting analysis (n = 3). MSP data presented as mean ± standard error of the mean, *P ≤ 0.05, **P ≤ 0.01, ***P ≤ 0.001, n-number of independent experiments
| The Cxcl12 expression related to the activities of TETs
The obtained results pointed to the possibility that TET1 and TET2
were crucial for enhancing Cxcl12 expression via gene promoter de- 
| D ISCUSS I ON
Our previous results based on transfection experiments revealed that PARP-1 plays a role in suppression of the Cxcl12 promoter. 
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Also, CXCL12 possesses an anti-diabetogenic potential due to promotion of beta-cell survival and its involvement in the regulation of beta-cell mass in pancreas, suggesting that manipulation of Cxcl12 gene expression could be used in a potential diabetes treatment. 6, [19] [20] [21] [22] Furthermore, we recently showed that the DNA methylation profile of Cxcl12 gene played an important role in progression of periodontitis. 23 It was reported that epigenetic down-regulation of Cxcl12 is involved in breast carcinoma, higher proliferation rates of breast cancer cells, non-small cell lung cancer and lymph node metastasis development. 24 Epigenetic down-regulation of Cxcl12 expression by hypermethylation mediated by DNMT1 was documented in osteosarcoma. 25 Additionally, the observation that DNMT1 inhibition restored CXCL12 secretion, which consequently suppressed tumour growth and retained osteosarcoma progression, was in accordance with the overall survival effect connected with increased Cxcl12 expression. 25 Hence, due to the potential antitumor effect of ele- expression. According to literature data, depletion of PAR leads to silencing of Dnmt1 by hypermethylation, which accounts for defective methylation activity and consequently demethylation processes. 3, 26 Furthermore, site-specific demethylation has also been documented for gene promoters as a result of PARP-1 depletion. 3, 27 According to our results, changes in Dnmts expression were not statistically significant. We assumed that the detected decrease in Considering the potential involvement of TET-dependent demethylation of Cxcl12, which could be responsible for its elevated expression in PARP1−/− cells, we performed experiments with TET enzyme activator (VitC) and inhibitor (DMOG) in order to verify whether TET activity is involved, at least in part, in the modulation of Cxcl12 gene expression. Vitamin C promotes TET-dependent DNA demethylation in embryonic stem cells and increases 5hmC levels through enhanced Fe 2+ recycling. [30] [31] [32] [33] On the other hand, DMOG is a small-molecule, an analogue of 2-oxoglutarate which inhibits members of 2-oxoglutarate-dependent dioxygenases, and is known to impede the enzymatic activity of TET enzymes. 34, 35 In 
